الصفحة الرئيسية>>m7G(5')ppp(5')(2'OMeA)pG

m7G(5')ppp(5')(2'OMeA)pG

رقم الكتالوجGN20149

m7G(5')ppp(5')(2'OMeA)pG is a co-transcriptional capping reagent resulting in a Cap 1 structures.

Products are for research use only. Not for human use. We do not sell to patients.

m7G(5')ppp(5')(2'OMeA)pG التركيب الكيميائي

الحجم السعر المخزون الكميّة
1µmole
294٫00
متوفر
5µmole
1354٫00
متوفر
10µmole
2533٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com


مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Product Documents

Quality Control & SDS

View current batch:

Description

m7G(5')ppp(5')(2'OMeA)pG is a co-transcriptional capping reagent resulting in a Cap 1 structures. m7G(5')ppp(5')(2'OMeA)pG is commonly used for in vitro transcription of 5'-capped mRNA with a capping efficiency of up to 98%. The capping efficiency of m7G(5')ppp(5')(2'OMeA)pG depends on multiple factors, including m7G(5')ppp(5')(2'OMeA)pG, DNA template, final RNA length, RNA base composition, and secondary structure formed by RNA.

m7G(5')ppp(5')(2'OMeA)pG requires a specific 5' AG 3' initiation sequence and is compatible with wild-type T7 polymerase.

Product Details

purity >95.00% Extinction Coefficient 30,539 Lmol-1cm-1 at 255 nm
Formula C32H43N15O24P4 (free acid) M.Wt 1145.60 g/mole (free acid)
Salt Form Na+ تركيز 100 mM
Buffer H2O Storage -20°C or below
المرادفات m7GpppAmpG Backbone 5'-5'-Triphosphate
Base Analog Adenosine, Guanosine Sugar Type
Nucleotide Category Cap analogs
تطبيقات CRISPR, In vitro Transcription, Recombinases, TALENS, Transposases, Vaccine Development, Zinc Finger Nucleases

مراجعات

Review for m7G(5')ppp(5')(2'OMeA)pG

Average Rating: 5 ★★★★★ (Based on Reviews and 34 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for m7G(5')ppp(5')(2'OMeA)pG

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.